{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:41:13Z","timestamp":1778960473763,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071610831","type":"print"},{"value":"9781071610848","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1084-8_10","type":"book-chapter","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T08:03:03Z","timestamp":1606118583000},"page":"153-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling"],"prefix":"10.1007","author":[{"given":"Chun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukaina","family":"Himmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazish","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917\u20131920. https:\/\/doi.org\/10.1126\/science.1151526","journal-title":"Science"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.jacc.2016.01.083","volume":"67","author":"N Sayed","year":"2016","unstructured":"Sayed N, Liu C, Wu JC (2016) Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine. J Am Coll Cardiol 67:2161\u20132176. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.083","journal-title":"J Am Coll Cardiol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/eurheartj\/ehx089","volume":"38","author":"N Sayed","year":"2017","unstructured":"Sayed N, Wu JC (2017) Towards cardio-precision medicine. Eur Heart J 38:1014\u20131016. https:\/\/doi.org\/10.1093\/eurheartj\/ehx089","journal-title":"Eur Heart J"},{"key":"10_CR5","doi-asserted-by":"publisher","unstructured":"Liu C, Oikonomopoulos A, Sayed N, Wu JC (2018) Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. Development 145(5). pii: dev156166. https:\/\/doi.org\/10.1242\/dev.156166","DOI":"10.1242\/dev.156166"},{"key":"10_CR6","doi-asserted-by":"publisher","unstructured":"Bozzi A, Sayed N, Matsa E, Sass G, Neofytou E, Clemons KV, Correa-Oliveira R, Stevens DA, Wu JC (2019) Using human induced pluripotent stem cell-derived cardiomyocytes as\u00a0a model to study Trypanosoma cruzi infection. Stem Cell Rep 12:1232\u20131241. https:\/\/doi.org\/10.1016\/j.stemcr.2019.04.017","DOI":"10.1016\/j.stemcr.2019.04.017"},{"key":"10_CR7","doi-asserted-by":"publisher","unstructured":"Sayed N, Liu C, Ameen M, Himmati F, Zhang JZ, Khanamiri S, Moonen JR, Wnorowski A, Cheng L, Rhee JW, Gaddam S, Wang KC, Sallam K, Boyd JH, Woo YJ, Rabinovitch M, Wu JC (2020) Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy. Sci Transl Med 12(554):eaax9276. https:\/\/doi.org\/10.1126\/scitranslmed.aax9276","DOI":"10.1126\/scitranslmed.aax9276"},{"key":"10_CR8","doi-asserted-by":"publisher","unstructured":"Rhee JW, Yi H, Thomas D, Lam CK, Belbachir N, Tian L, Qin X, Malisa J, Lau E, Paik DT, Kim Y, Choi BS, Sayed N, Sallam K, Liao R, Wu JC (2020) Modeling secondary iron overload cardiomyopathy with human induced pluripotent stem cell-derived cardiomyocytes. Cell Rep 32(2):107886. https:\/\/doi.org\/10.1016\/j.celrep.2020.107886","DOI":"10.1016\/j.celrep.2020.107886"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA","volume":"139","author":"T Kitani","year":"2019","unstructured":"Kitani T, Ong S-G, Lam CK, Rhee J-W, Zhang JZ, Oikonomopoulos A, Ma N, Tian L, Lee J, Telli ML, Witteles RM, Sharma A, Sayed N, Wu JC (2019) Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer. Circulation 139:2451\u20132465. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA","journal-title":"Circulation"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/cvr\/cvz024","volume":"115","author":"N Sayed","year":"2019","unstructured":"Sayed N, Ameen M, Wu JC (2019) Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell. Cardiovasc Res 115:949\u2013959. https:\/\/doi.org\/10.1093\/cvr\/cvz024","journal-title":"Cardiovasc Res"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/eurheartj\/ehx811","volume":"40","author":"JP Stack","year":"2018","unstructured":"Stack JP, Moslehi J, Sayed N, Wu JC (2018) Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it? Eur Heart J 40:1764\u20131770. https:\/\/doi.org\/10.1093\/eurheartj\/ehx811","journal-title":"Eur Heart J"},{"key":"10_CR12","doi-asserted-by":"publisher","unstructured":"Sharma A, Burridge PW, McKeithan WL, Serrano R, Shukla P, Sayed N, Churko JM, Kitani T, Wu H, Holmstr\u00f6m A, Matsa E, Zhang Y, Kumar A, Fan AC, del \u00c1lamo JC, Wu SM, Moslehi JJ, Mercola M, Wu JC (2017) High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci Transl Med 9(377). pii: eaaf2584. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2584","DOI":"10.1126\/scitranslmed.aaf2584"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata K-I, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M (2017) Autologous induced stem-cell\u2013derived retinal cells for macular degeneration. N Engl J Med 376:1038\u20131046. https:\/\/doi.org\/10.1056\/NEJMoa1608368","journal-title":"N Engl J Med"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nmeth.1426","volume":"7","author":"F Jia","year":"2010","unstructured":"Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC (2010) A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7:197\u2013199. https:\/\/doi.org\/10.1038\/nmeth.1426","journal-title":"Nat Methods"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nbt1483","volume":"26","author":"M Wernig","year":"2008","unstructured":"Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R (2008) A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26:916\u2013924. https:\/\/doi.org\/10.1038\/nbt1483","journal-title":"Nat Biotechnol"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nature07863","volume":"458","author":"K Woltjen","year":"2009","unstructured":"Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, H\u00e4m\u00e4l\u00e4inen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung H-K, Nagy A (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766\u2013770. https:\/\/doi.org\/10.1038\/nature07863","journal-title":"Nature"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nbt1418","volume":"26","author":"D Huangfu","year":"2008","unstructured":"Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26:795\u2013797. https:\/\/doi.org\/10.1038\/nbt1418","journal-title":"Nat Biotechnol"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.aaa5458","volume":"349","author":"P Hou","year":"2013","unstructured":"Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 349:982\u2013986. https:\/\/doi.org\/10.1126\/science.aaa5458","journal-title":"Science"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","volume":"4","author":"H Zhou","year":"2009","unstructured":"Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Sch\u00f6ler HR, Duan L, Ding S (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381\u2013384. https:\/\/doi.org\/10.1016\/j.stem.2009.04.005","journal-title":"Cell Stem Cell"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","volume":"4","author":"D Kim","year":"2009","unstructured":"Kim D, Kim C-H, Moon J-I, Chung Y-G, Chang M-Y, Han B-S, Ko S, Yang E, Cha KY, Lanza R, Kim K-S (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472\u2013476. https:\/\/doi.org\/10.1016\/j.stem.2009.05.005","journal-title":"Cell Stem Cell"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/bit.22517","volume":"104","author":"WC Yang","year":"2009","unstructured":"Yang WC, Patel KG, Lee J, Ghebremariam YT, Wong HE, Cooke JP, Swartz JR (2009) Cell-free production of transducible transcription factors for nuclear reprogramming. Biotechnol Bioeng 104:1047\u20131058. https:\/\/doi.org\/10.1002\/bit.22517","journal-title":"Biotechnol Bioeng"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cell.2012.09.034","volume":"151","author":"J Lee","year":"2012","unstructured":"Lee J, Sayed N, Hunter A, Au Kin F, Wong Wing H, Mocarski Edward S, Pera Renee R, Yakubov E, Cooke John P (2012) Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151:547\u2013558. https:\/\/doi.org\/10.1016\/j.cell.2012.09.034","journal-title":"Cell"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/stem.2607","volume":"35","author":"N Sayed","year":"2017","unstructured":"Sayed N, Ospino F, Himmati F, Lee J, Chanda P, Mocarski ES, Cooke JP (2017) Retinoic acid inducible gene 1 protein (RIG1)-like receptor pathway is required for efficient nuclear reprogramming. Stem Cells 35:1197\u20131207. https:\/\/doi.org\/10.1002\/stem.2607","journal-title":"Stem Cells"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1161\/circulationaha.113.007394","volume":"131","author":"N Sayed","year":"2015","unstructured":"Sayed N, Wong WT, Ospino F, Meng S, Lee J, Jha A, Dexheimer P, Aronow BJ, Cooke JP (2015) Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation 131:300\u2013309. https:\/\/doi.org\/10.1161\/circulationaha.113.007394","journal-title":"Circulation"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.stemcr.2020.01.006","volume":"14","author":"C Liu","year":"2020","unstructured":"Liu C, Ruan H, Himmati F, Zhao M-T, Chen CC, Makar M, Chen IY, Sallam K, Mocarski ES, Sayed D, Sayed N (2020) HIF1\u03b1 regulates early metabolic changes due to activation of innate immunity in nuclear reprogramming. Stem Cell Rep 14:192\u2013200. https:\/\/doi.org\/10.1016\/j.stemcr.2020.01.006","journal-title":"Stem Cell Rep"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fcell.2017.00070","volume":"5","author":"C Liu","year":"2017","unstructured":"Liu C, Himmati F, Sayed N (2017) Paying the toll in nuclear reprogramming. Front Cell Dev Biol 5:70. https:\/\/doi.org\/10.3389\/fcell.2017.00070","journal-title":"Front Cell Dev Biol"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.gde.2014.11.002","volume":"28","author":"JP Cooke","year":"2014","unstructured":"Cooke JP, Sayed N, Lee J, Wong WT (2014) Innate immunity and epigenetic plasticity in cellular reprogramming. Curr Opin Genet Dev 28:89\u201391. https:\/\/doi.org\/10.1016\/j.gde.2014.11.002","journal-title":"Curr Opin Genet Dev"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1242\/dev.020867","volume":"136","author":"K Hochedlinger","year":"2009","unstructured":"Hochedlinger K, Plath K (2009) Epigenetic reprogramming and induced pluripotency. Development 136:509\u2013523. https:\/\/doi.org\/10.1242\/dev.020867","journal-title":"Development"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrm3036","volume":"12","author":"A Gaspar-Maia","year":"2011","unstructured":"Gaspar-Maia A, Alajem A, Meshorer E, Ramalho-Santos M (2011) Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol 12:36\u201347. https:\/\/doi.org\/10.1038\/nrm3036","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Methods in Molecular Biology","Nuclear Reprogramming"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1084-8_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T08:49:19Z","timestamp":1606121359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-1084-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"ISBN":["9781071610831","9781071610848"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1084-8_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"24 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}